生物
可药性
蛋白质组
脂质代谢
蛋白质-蛋白质相互作用
计算生物学
生物化学
细胞生物学
药物发现
蛋白质组学
脂滴
基因
作者
Micah J. Niphakis,Kenneth M. Lum,Armand B. Cognetta,Bruno E. Correia,Taka-Aki Ichu,Jose Olucha,Steven S. Brown,Soumajit Kundu,Fabiana Piscitelli,Hugh Rosen,Benjamin F. Cravatt
出处
期刊:Cell
[Elsevier]
日期:2015-06-18
卷期号:161 (7): 1668-1680
被引量:167
标识
DOI:10.1016/j.cell.2015.05.045
摘要
Lipids play central roles in physiology and disease, where their structural, metabolic, and signaling functions often arise from interactions with proteins. Here, we describe a set of lipid-based chemical proteomic probes and their global interaction map in mammalian cells. These interactions involve hundreds of proteins from diverse functional classes and frequently occur at sites of drug action. We determine the target profiles for several drugs across the lipid-interaction proteome, revealing that its ligandable content extends far beyond traditionally defined categories of druggable proteins. In further support of this finding, we describe a selective ligand for the lipid-binding protein nucleobindin-1 (NUCB1) and show that this compound perturbs the hydrolytic and oxidative metabolism of endocannabinoids in cells. The described chemical proteomic platform thus provides an integrated path to both discover and pharmacologically characterize a wide range of proteins that participate in lipid pathways in cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI